I don’t vaccinate at all, so no.
I’ve spent about 16 years researching the subject (in medical journals, textbooks, product inserts, other such sources).
One of my concerns with this one (and with some others, esp. hep B) is changes in epidemiology down the road as a result of widespread use.
Duration of vaccine-induced immunity is unknown with a new vaccine (at least beyond a certain, limited point) and vaccine-induced immunity is typically much less than the immunity induced by exposure to/infection with the naturally occuring organism.
As with hep B, another mainly sexually transmitted infection for which the vaccine is being administered to the very young and those at lowest risk of exposure, when immunity wanes (not if, WHEN, based on all we know about vaccines and immunology) in say, 20 years, the recipients will be left with no natural immunity to protect them, and at a time when their risks of exposure are greatest. (adulthood when they are sexually active, and in the case of hep B, at risk of passing the infection on to their infants at birth, when the risks of serious complications, for the infant, are highest).
Ok, so we’ll just give a booster. No problem. Wrong. The reason hep B is administered to infants and children is that the approach of vaccinating adults, esp. those in high risk populations, was tried and failed miserably. (as it tends to compared to mandatory vaccination of infants and children…you cannot force an adult to be vaccinated in most cases, and uptake tends to be far below the threshhold necessary for “herd” immunity).
The same problem does and will exist with HPV vaccine.
FTR, I base my claim of the reasoning behind the hep B mandate on records from CDC meetings and statements made by scientists involved. Other rationales are put forth as well, but they are minor compared to the issue of uptake.
The vast majority of women exposed to HPV clear the infection from their system quickly and gain immunity to reinfection, probably for life. (same as with hep B)
The vaccine will prevent (or is intended to, anyway) infection and the development of natural immunity, resulting in millions of adult women lacking immunity to this very common organism(s) at a time when they will tend to be at much higher risk for exposure/infection and the complications sometimes involved.
I agree with the OP that too little is yet known about this vaccine, not only its safety for the individual recipient at the time but about its effect on the epidemiology of this infection, a much more serious concern.